Bausch HealthBHC +5.81%58 Days Payable is 73.75 as of Mar. 2026, which is 6% above its 10-year median of 69.57. GuruFocus rates BHC with a GF Score™ of 58/100 and a GF Value™ of $7.91 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 923 Drug Manufacturers companies, Bausch Health ranks worse than 59.91% on this metric.
The historical rank and industry rank for Bausch Health's Days Payable or its related term are showing as below:
BHC'
s Days Payable Range Over the Past 10 Years
Min: 50.39 Med: 69.57 Max: 88.9
Current: 73.79
During the past 13 years, Bausch Health's highest Days Payable was 88.90. The lowest was 50.39. And the median was 69.57.
BHC's Days Payable is ranked worse than 59.91% of 923
companies
in the Drug Manufacturers industry
Industry Median: 90.98
vs BHC: 73.79
Bausch Health's Days Payable
declined
from Mar. 2025 (78.69) to Mar. 2026 (73.75).
It may suggest that Bausch Healthaccelerated paying its suppliers.
Bausch Health Days Payable Related Terms
Bausch Health Days Payable Historical Data
* Premium members only.
The historical data trend for Bausch Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bausch Health Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Bausch Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Bausch Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bausch Health (BHC) has a Days Payable of 73.75 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bausch Health and its competitors. This is near median its historical median of 69.57. Over the past decade, Bausch Health's Days Payable has ranged from 50.39 to 88.90. According to the industry distribution chart, Bausch Health ranks #553 out of 923 companies in the Drug Manufacturers industry, placing it in the top 59.9%.
Is Bausch Health's Days Payable too high?
Bausch Health's current Days Payable of 73.75 is near median its 10-year median of 69.57. Over the past 10 years, this metric has ranged from a low of 50.39 to a high of 88.90. The Drug Manufacturers industry median Days Payable is 90.98. Bausch Health's value of 73.75 is 18.9% below this industry median. Based on the distribution chart, Bausch Health ranks #553 out of 923 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Bausch Health has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Bausch Health ranks #553 out of 923 companies for Days Payable. This places Bausch Health in the lower half of its industry. The industry median Days Payable is 90.98. Bausch Health's value of 73.75 is 18.9% below this benchmark. Historically, Bausch Health's own Days Payable has ranged from 50.39 to 88.90 over the past decade. While the company's 10-year median is 69.57 vs. the industry median of 90.98, Bausch Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bausch Health's current Days Payable of 73.75 is 18.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Bausch Health and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bausch Health's current Days Payable is 73.75, which is near median its own 10-year median of 69.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (BHC) is currently considered Possible Value Trap. The stock's GF Value™ is $7.91, compared to a current price of $5.28 — trading 33.2% below its estimated fair value. The current Days Payable is 73.75, which is near median its 10-year median of 69.57 and 18.9% below the Drug Manufacturers industry median of 90.98. Bausch Health's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Bausch Health (BHC), the current Days Payable is 73.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bausch Health (BHC) Overvalued in 2026?
Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued.
The current stock price of $5.28 is trading 33.2% below its estimated GF Value™ of $7.91.
GuruFocus considers Bausch Health to be Possible Value Trap.
Key valuation signals for BHC:
Days Payable: 73.75 (near median its 10-year median of 69.57)
GF Value™: $7.91 vs. price of $5.28 (33.2% below fair value)
Industry Position: 18.9% below the Drug Manufacturers median (#553 of 923)
No single metric tells the full story. See the BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
58GF Score
Get the complete analysis for BHC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHC has been successfully added to your 
